BRIAN BIZIK: Open Payments
NPI 1932166956 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$29,527 in 65 payments from 10 companies in 2025. Trend: 2023 $8,260 · 2024 $24,153 · 2025 $29,527
Speaker / faculty: $12,312Honoraria: $6,650Travel & lodging: $4,563Consulting: $4,507Food & beverage: $1,495
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 26 | $9,983 |
| Regeneron Healthcare Solutions, Inc. | 10 | $8,690 |
| PFIZER INC. | 4 | $3,600 |
| Grifols USA, LLC | 14 | $2,636 |
| Regeneron Pharmaceuticals, Inc. | 2 | $1,656 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $1,562 |
| GENZYME CORPORATION | 1 | $936 |
| AstraZeneca Pharmaceuticals LP | 3 | $322 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $17 |
Products named: DUPIXENT, VTAMA, PAXLOVID, Prolastin-C Liquid, NEFFY, AIRSUPRA, BREZTRI, FASENRA.
Industry payments across ID — which companies pay providers there.
